12:00 AM
 | 
May 28, 2012
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Eisai sales and marketing update

Eisai's Eisai Europe Ltd. subsidiary launched Zebinix eslicarbazepine acetate in Sweden as an adjunct therapy for epilepsy in adults with...

Read the full 88 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >